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Objective: Modern treatment of peptic ulcers includes antibacterial 
and gastroprotective medications. However, current anti-ulcer 
drugs possess severe side effects. Therefore, all attempts to find new 
effective medications free from side effects are justified. Though 
Berberis vulgaris is a medicinal plant commonly used for the 
treatment of numerous disorders, gastroprotective effect of its leaf 
extract was not investigated before.  
Materials and Methods: Gastric ulcer was modelled in Sprague-
Dawley rats after treatment with B. vulgaris leaf extract containing 
0.07% of alkaloids, 0.48% of flavonoids and 8.05% of tanning 
substances, 10 or 50 mg of dry extract/kg, changes in the stomach 
mucosa were assessed semi-quantitatively, and the gastric wall was 
evaluated for prostaglandin E2 level using ELISA and assessed 
histologically by calculation of the lesion index. 
Results: B. vulgaris leaf extract at the dose of 50 mg/kg reduced the 
macroscopic ulcer score and the microscopic lesion index, increased 
prostaglandin E2 concentration in the gastric wall significantly 
higher than atropine and B. vulgaris leaf extract 10 mg/kg. 
Conclusion: The gastroprotective effect of the high dose of B. 
vulgaris leaf extract may be due to stimulation of prostaglandin E2 
secretion in the stomach, and anti-oxidative and anti-inflammatory 
properties of polyphenolic complex of flavonoids and tannins 
present in the leaves of this plant. 
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Introduction 
Gastric ulcer is one of the most common 
diseases causing life-threatening 
complications, such as perforation of the 
gastric wall and bleeding. In addition, 
gastric ulcer reduces the quality of life of 
patients and is a potential risk of cancer 
(Komar et al., 2018; Yegen, 2018; Kavitt et 
al., 2019; Tarasconi et al., 2020). The 
etiological factor in the development of 
gastric ulcer is Helicobacter pylori (H. 
pylori), whose incidence in developed 
countries reaches 10% (Quach et al., 2018). 
Irritation of the gastric mucosa and 
cholinergic activation caused by smoking, 
hydrochloric acid, pepsin, ischemia, 
nonsteroidal anti-inflammatory drugs 
(NSAIDs), hypoxia, alcohol, etc. may 
damage the mucosal barrier and provoke 
ulceration. Many other mechanisms have 
been implicated in the pathogenesis of 
gastric ulcers, including inhibition of 
prostaglandin synthesis and cell 
proliferation, and changes in gastric blood 
flow, and gastric motility (Cryer, 2001; 
Toma et al., 2005; Tytgat, 2011; Tarasconi 
et al., 2020). 
Modern therapy of gastric ulcers 
includes antimicrobial treatment and 
protection of the gastric mucosa. However, 
the development of H. pylori, resistance 
significantly reduces the effectiveness of 
antibiotic treatment (Ahmad et al., 2019; 
Suzuki et al., 2019). Currently used anti-
ulcer agents, such as H2 antagonists, proton 
pump inhibitors, prostaglandin analogs, and 
cholinoblockers, have significant side 
effects. Moreover, recently, serious 
problems were shown for H2 antagonists, 
which were considered to be among the 
most effective anti-ulcer medications, as a 
toxic impurity was found in ranitidine drug 
products. In April 2020, the FDA requested 
to withdraw ranitidine from the market in 
the United States, since a contaminant 
known as N-Nitrosodimethylamine 
(NDMA) was determined in ranitidine 
products during storage, including home 
storage, at unacceptable levels (FDA, 
2020). Thus, the problem of gastric ulcer 
treatment, which seemed to be almost 
solved, becomes relevant again, and 
attempts to discover new drugs with lower 
cost and fewer side effects need to be 
undertaken (Al-Sayed et al., 2020).  
Natural products are an essential 
resource for the prevention and treatment of 
gastric ulcers (Berłowski et al., 2013; 
Ahmad et al., 2019; Al-Sayed et al., 2020). 
Barberry (Berberis vulgaris L., Var. 
asperma Don., family Berberidaceae) is 
traditionally cultivated in Iran (especially in 
Birjand and Qaen) where it is known as 
"zereshk"; it also grows in the south of 
Europe and northeast of the USA; it has 
been widely used in traditional medicine for 
the treatment of cardiovascular and 
metabolism disorders (El-Wahab et al., 
2013; Tabeshpour et al., 2017; Asadi et al., 
2019; Imenshahidi and  Hosseinzadeh, 
2019). Medicinal properties for all parts of 
the plant have been reported, including 
antimicrobial, antioxidant, anti-
inflammatory and anticholinergic actions 
(Mokhber-Dezfuli et al., 2014; Abushouk et 
al., 2917; Rahimi-Madiseh et al., 2017; 
Mirhadi et al., 2018; Kalmarzi et al., 2019). 
This plant has been for a long time used for 
the treatment of gastrointestinal disorders 
(Majeed et al., 2015; Zarei et al., 2015; 
Imenshahidi and Hosseinzadeh, 2016). 
Barberry fruit extract showed antioxidant 
properties and an inhibitory activity on 
Helicobacter pylori growth; its 
gastroprotective effect was demonstrated to 
be mediated through modulation of nitric 
oxide synthase (iNOS) gene expression: 
activation of endothelial nitric oxide 
synthase (eNOS) and inhibition of 
inducible nitric oxide synthase (iNOS) 
(Fazaei et al., 2013). To the best of our 
knowledge, so far, no studies have been 
done to investigate the effect of B. vulgaris 
leaf extraction (BV) on gastric ulcer. 
Therefore, we have undertaken this study to 
evaluate the gastroprotective effect of BV 
on ethanol-induced gastric mucosal injury 
in rats. 
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Materials and Methods 
Material  
Berberis vulgaris leaves were harvested 
in the Botanic garden of the Sechenov 
University (Moscow, Russia, 
55°44'46.615" N 37°31'48.886" E) in 
summer 2014 in a phase of full 
development.  Plant samples were 
identified at the Department of 
Pharmacognosy of the Pharmaceutical 
Faculty of the Sechenov University and 
placed in the department herbarium 
(herbarium number: 00725/150614). Their 
1:10 extract was prepared using 70% 
alcohol using percolation and consequent 
sedimentation during 48 hr at 10°C. The 
extract obtained met all the requirements of 
the Russian State Pharmacopea XIII. The 
presence of the biologically active 
substances in the extract of the B. vulgaris 
leaves was confirmed using qualitative 
reactions. Alkaloids were detected using 
Dragendorff's reagent producing orange-
red precipitate, flavonoids - using 1% 
aluminum chloride in 95% alcohol, 
producing yellow-green staining. At the 
same time, tanning substances were 
determined using ferric ammonium sulfate, 
giving blue-green color. 
Spectrophotometrically alkaloids 
content in the extract was determined as 
0.070±0.018% and flavonoids as 
0.48±0.09%, while tanning substances 
content was estimated as 8.05±0.17% by 




A total of 30 Sprague-Dawley rats 
weighing 200-250 g were involved in the 
study. They were divided into 5 groups with 
6 rats per group: 3 control and 2 
experimental groups. The 1st group (N) and 
2nd group (A) of negative control received 
normal saline, the 3rd group of positive 
control (A+At) – 50 mg/kg of atropine, the 
4th group (A+b) – BV (10 mg of dry 
extract/kg), and the 5th group (A+B) - BV 
(50 mg/kg). After 30 min, animals of the N 
group received normal saline, while the rest 
of the groups received absolute alcohol (0.5 
ml/kg of weight) to induce stomach ulcer as 
recommended (Pan et al., 2005). After 1 hr, 
animals were sacrificed under ketamine 
anaesthesia. The stomach was removed, the 
content was tested for pH, the organ was cut 
along the greater curvature, rinsed with 
distilled water, spread on the pad using 
needles, and assessed visually for the depth 
of the lesions. Scoring of the ulcer was 
made as follows: normal coloured stomach 
(0), red coloration (0.5), spot ulcer (1), 
hemorrhagic streak (1.5), deep ulcers (2), 
perforation (3) as described earlier 
(Dashputre and Naikwade, 2011). The 
anterior wall of the stomach was sampled 
for ELISA (PgE2), and the posterior wall 
was fixed in formalin and processed for 
histological evaluation of the alcohol-
induced lesions. The histological slides 3 
μm thick were stained with hematoxylin-
eosin and assessed independently by two 
researchers semi-quantitatively for the 
microscopic lesions.  
 
Reagents and equipment 
The following chemicals and equipment 
were used in the study: 
- Phosphate Buffered Solution (PBS), 
Sigma Aldrich 
- Lysis Buffer 17 (R&D system, Abingdon, 
UK, catalog #895943) 
- Microplate reader capable of measuring 
absorbance at 450 nm, (Victor X, Perkin 
Elmer, USA) 
- Tissue homogenizer, (Omni-Ruptor 4000, 
OMNI International Inc., US) 
- Horizontal orbital shaker with the speed of 




In our research, pH of the gastric content 
was tested using litmus paper (More et al., 
1983). Macroscopic evaluation of ulcer 
scoring was done as recommended 
(Dashputre and Naikwade, 2011).  
For ELISA, 100 mg of rat stomach tissue 
was washed with 0.1 M phosphate buffer 
and lysed in 1 ml of homogenization buffer 
Kapitonova et al. 
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(0.1 M phosphate buffer, pH 7.4 containing 
1 mM EDTA and 10 mm indomethacin) 
using tissue homogenizer. Then, samples 
lysate was centrifuged at 8,000 x g for 10 
min to pellet particulate matter. The 
supernatant was transferred into a clean 1.5 
ml tube. Prostaglandin E2 concentration in 
samples was assayed using the 
Prostaglandin E2 express EIA kit 
(Caymanchem). Data analysis was done 
using spreadsheets available at 
www.caymanchem.com/analysis/eia 
according to the manufacturer protocol 
using microplate reader VictorTM X, 
Perkin Elmer, US, at 450 nm wavelength. 
The optical density reading of the sample at 
450 nm wavelength was subtracted with 
570 nm wavelength to avoid imperfection 
plate. The results of the ELISA are 
expressed as pg/mL. The lesion index was 
estimated by two independent researchers 
as recommended (Nur Azlina et al., 2013).  
 
Statistical analysis 
All data are presented as the 
mean±SEM, with n=6 per group. The 
results were analyzed by one-way analysis 
of variance (ANOVA) followed by 
Student–Newman–Keuls multiple 
comparison test; p<0.05 values were 
considered statistically significant. 
   
 
Result 
Determination of the pH of the gastric 
content 
The results are shown in Figure1. As 
follows from Figure1, the pH of the gastric 
content in the groups A+At and A+b was 
significantly higher compared to the group 
A (p<0.05 and p<0.01, respectively). There 
was no significant difference in the pH 
between the groups A+At and A+b 
(p>0.05), while in the group A+B, it was 
significantly higher than all the other 
groups (p<0.001 compared to the group A 




The study revealed a significant 
damaging effect of ethanol on gastric 
mucosa (Figure 2a). At the same time, the 
animals which received only normal saline 
showed no changes on the inner surface of 
the stomach. The animals that received 
ethanol (group A) developed a considerable 
macroscopic mucosal damage evidenced by 
the presence of extensive ulcerations and 
haemorrhages (Figure 2b) covering more 
than 80% of the gastric mucosa. The area 
and intensity were somewhat reduced by 
the administration of atropine (the group 
A+At) with a decreased area of gastric 
mucosal necrosis, erosions, haemorrhages, 
and hyperemia (Figure 2c) covering more 




Figure 1. pH of the gastric content in study rats (Mean±SEM). 
A-alcohol (negative control) *p<0.05 compared to A            
A+At-alcohol+atropine **p<0.01 compared to A  
A+b-alcohol+BV (10 mg) ***p<0.001 compared to A        
A+B-alcohol+BV (50 mg) +p<0.05 compared to A+At. #p<0.05 compared to A+b 
Gastroprotective effect of Berberis vulgaris 
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However, combined administration of 
ethanol with BV showed macroscopic 
toxicity attenuation, preserving the most of 
morphological integrity of the gastric 
mucosa with the presence of gastric 
erosions and haemorrhages covering up to 
30% in the group A+b and generalized 
erythema with occasional mucosal 
haemorrhages seen in the animals of the 
group A+B for 10 mg/kg and 50 mg/kg of 
BV.  
The results of ulcer scoring are shown in 
Figure 3. As shown in Figure 3, the ulcer 
score was reduced in the A+At group 
compared to the A group, but this reduction 
was not significant (p>0.05). It was 
significantly (p<0.05) and highly 
significantly (p<0.001) reduced in the A+b 
and A+B groups compared to the A group 
respectively; moreover, in the group A+B, 
it was significantly reduced compared to 
the groups A+At (p<0.001) and A+b 
(p<0.05). In the group A+b, the ulcer score 
was lower compared to the group A+At, but 





Figure 2. The gross appearance of gastric mucosa 
in the control and experimental rats. 
a) Ethanol-treated group (Group A): severe 
injuries to the stomach mucosa with diffuse 
hyperemia, multiple petechiae, and slouched-off 
superficial gastric mucosa, especially at the top of 
the gastric folds, revealing multiple erosions 
covered with whitish slough. 
b) Atropine-treated group (Group A+At): less 
severe necroerosive lesions within the gastric 
mucosa revealing focal hyperaemia with swollen 
folds and superficial erosions. 
c) BV-treated group (Group A+b, 10 mg/kg): 
moderate focal haemorrhages and disruptions of 
the surface lining of the stomach. 
d) BV-treated group (Group A+B, 50 mg/kg): 
mild hyperaemia and minimal focal 
haemorrhages with mild disruptions of the 
surface lining in the gastric mucosa and slightly 
swollen mucosal folds. 
 
   
 
Figure 3. Ulcer scoring in the study rats (Mean±SEM). 
A-alcohol (negative control) and *p<0.05 compared to the group A. 
A+At-alcohol+atropine ***p<0.001 compared to the group A 
A+b-alcohol+BV (10 mg) +++p<0.001 compared to the group A+At 
A+B-alcohol+BV (50 mg) #p<0.05   compared to the group A
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Measurement of the content of 
prostaglandin E2 in the gastric wall 
using ELISA 
As shown in Figure 4, the level of PGE2 
in the wall of animals from the group A was 
highly significantly reduced compared to 
the normal rats (p<0.001). In group A+At, 
it was significantly higher compared to the 
group A (p<0.01), but it was significantly 
lower than that of the normal rats (p<0.01). 
In the group A+B, it was significantly 
higher than the group A (p<0.01) and group 
A+At (p<0.05), while it was slightly higher 
without reaching the level of significance 
(p>0.05) than the normal rats. 
 
Histopathological study 
    Histopathological study of gastric lesions 
in the ethanol-treated group (group A) 
displayed marked changes in gastric 
mucosa and submucosa including severe 
necrosis and desquamation of mucosal 
epithelial cell, vacuolization, oedema and 
some dilation of gastric glands along with 
infiltration of inflammatory cells 
(neutrophils), haemorrhage in lamina 
propria, degenerative changes in gastric 
glands, congestion of blood and oedema in 
submucosal layer with scattered 
inflammatory cells, mostly neutrophils. 
  Pre-treatment with atropine (group A+At) 
demonstrated less pronounced gastric 
damage compared to the ulcer-negative 
control (group A). The gastric mucosa 
exhibited focal necrosis limited to mucosa 
only, whereas, in other areas, the gastric 
glands were almost normal in appearance. 
There was mild submucosal oedema with 
scattered neutrophilic infiltration. Pre-
treatment with BV (10 mg/kg, group A+b) 
resulted in gastric lesions, characterized by 
focal areas of mild sloughing off of the 
epithelial cells and moderate mucosal 
oedema. Scattered neutrophils in 
submucosa were observed. However, in the 
group treated with a higher dose of BV (50 
mg/kg, group A+B), there was minimal 
sloughing of epithelial cells. Hence, the 
epithelium of gastric mucosa can be 
considered to be almost intact (Figure 5a, b, 
c, and d). 
The results of the estimation of the 
microscopic lesion index are shown in 
Figure 6. Lesion index was highly 
significantly reduced in the group A+At 
compared to the group A (p<0.001); it was 
also highly significantly reduced in the 
group A+b compared to the group A 
(p<0.001) and group A+At (p<0.01); and it 
was highly significantly reduced in the 
group A+B compared to the groups A 
(p<0.001) and A+At (p<0.001), and 
significantly reduced compared to the 
group A+b  (p<0.05). 
 
 
Figure 4. Prostaglandin E2 content (ng/ml) in the wall of the stomach of the study rats 
(Mean±SEM). 
N–normal rats, **p<0.01   compared to the group N  
A–alcohol (negative control); ***p<0.001 compared to the group N   
A+At– alcohol+atropine; ++p<0.01 compared to the group A  
A+B– alcohol+BV (50 mg) #p<0.05   compared to the group A+At 
Gastroprotective effect of Berberis vulgaris 
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Overall, the results of the experiment 
demonstrated that treatment with atropine 
significantly increased the pH of the gastric 
juice, while treatment with BV caused its 
highly significant increase, which was more 
prominent in the A+B experimental group. 
The effect of BV was dose-dependent, and 
the difference between A+b and A+B 
groups was significant. Atropine did not 
cause any significant decrease of the ulcer 
score, while this parameter was 
significantly decreased in the A+b group, 
and highly significant in the A+B group. 
The difference in the ulcer score between 
the A+B group and other treated groups was 
also significant. PGE2 content in the 
animals with untreated ulcers was 
significantly lower than in normal rats. 
Treatment with atropine increased PGE2 
content compared to untreated animals, but 
it was still much less than that of the normal 
animals. Treatment with BV 50 mg 
increased PGE2 to the normal level, making 
it highly significantly larger than in 
untreated and atropine-treated groups. The 
microscopic lesion index proved to be the 
most sensitive parameter of our study. It 
was highly significantly decreased in all 
treatment groups, while in the A+b group it 
was significantly lower than the A+At 
group; and in the A+B group; it was 






Figure 5. Microphotographs of the H&E stained 
histological slides of the stomach of the control and 
experimental rats. x100. a) Group A: marked 
changes in gastric mucosa and submucosa including 
severe necrosis and sloughing of the superficial 
mucosal epithelium with the formation of mucosal 
erosions, oedema with infiltration of inflammatory 
cells (neutrophils), haemorrhages in lamina propria, 
degenerative changes in gastric glands; in the 
submucosal layer: congestion of blood and oedema 
with scattered inflammatory cells, mostly 
neutrophils. b) Group A+At: less pronounced gastric 
damage compared to the Group A; the gastric 
mucosa exhibited focal necrosis with sloughed off 
superficial mucosal epithelium and formation of 
superficial focal erosions limited to the mucosa with 
scattered inflammatory infiltration predominantly 
with neutrophils, whereas in other areas the gastric 
glands were almost normal in appearance; mild 
submucosal oedema with scattered neutrophil 
infiltration. c) Group A+b: gastric lesions, 
characterized by focal areas of mild epithelial cells 
disruption and moderate mucosal oedema. Scattered 
neutrophils in submucosa were observed. d) Group 
A+B: almost normal epithelial lining with some 
focal superficial epithelial denudation. 
 
Figure 6. Lesion index in the stomach of study rats (Mean±SEM). 
A–alcohol (negative control) ***p<0.001 compared to the group A            
A+At–alcohol+atropine ++p<0.01 compared to the group A+At      
A+b–alcohol+BV (10 mg) +++p<0.001 compared to the group A+At           
A+B–alcohol+BV (50 mg) #p<0.0 compared to the group A+b 
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Discussion 
Despite the availability of highly 
effective drugs for the treatment of gastric 
ulcers, the prevalence of this disease 
remains high, and it continues to be a course  
of significant morbidity and mortality 
worldwide, therefore proper management is 
important for the minimization of serious 
complications (Komar et al., 2018; 
Narayanan et al., 2018; Roberts-Thomson, 
2018; Kavitt et al., 2019). The need to 
search for new alternative medications for 
the treatment of gastric ulcer is dictated by 
a number of factors. Currently, in the 
treatment of gastric ulcers, the drugs of 
choice are proton pump inhibitors (PPIs), 
which irreversibly inhibit H+K+ATPase in 
the parietal cells of the stomach and thereby 
reduce the secretion of hydrochloric acid. 
The high efficiency of PPIs creates the 
impression that there are no vacant niches 
in this segment of the pharmaceutical 
market (Halfdanarson et al., 2018). While 
the advantages of short-term PPIs 
administration are well documented, the 
consequences of long-term deep inhibition 
of hydrochloric acid secretion are to be 
further elucidated. It is known that there is 
an increased risk of neuroendocrine tumors 
and carcinoma with prolonged use of PPIs. 
Enterochromaffin cells are a target for 
gastrin, and hyperstimulation of these cells 
can lead to carcinogenesis in PPIs users 
(Tang et al., 2013). In addition, PPIs use is 
associated with a 1.76-fold increase in the 
risk of chronic kidney disease, which may 
be related to the blockage of kidney 
transport systems (Lazarus et al., 2016). 
Recent studies have found that long-term 
PPIs use is also associated with the 
development of dementia and Alzheimer's 
disease (Ortiz-Guerrero et al., 2018; 
Cooksey et al., 2020). Profound and long-
lasting inhibition of gastric acid secretion 
leads to disturbances in the absorption of 
vitamin B12, calcium, magnesium and iron, 
development of osteoporosis and, 
consequently, to an increased risk of bone 
fractures (Ajmera et al., 2012; Eusebi et al., 
2017; Freedberg et al., 2017; Ueberschaer 
and Allescher, 2017; Miller, 2018; Nassar 
and Richter, 2018). Along with this, it must 
be borne in mind that CYP2C19 genetic 
polymorphism, which affects the activity of 
PPIs, is widespread in the world, especially 
in Asia, where the incidence reaches 15-
20% (Tang et al., 2013). This leads to a 5-
10 time increase in the concentration of 
PPIs in the blood of poor metabolizers. 
These problems caused by the long-term 
use of PPIs necessitate the search for other 
options, fundamentally new drugs for the 
treatment of gastric ulcers (Bhatia et al., 
2015; Minaiyan et al., 2018; Boushra et al., 
2019; Raeesi et al., 2019). 
At the same time, phenolic compounds 
have been shown to play an essential role in 
the prevention of gastric ulceration 
(Sumbul et al., 2011; Farzaei et al., 2015; 
Gupta et al., 2020). In our experimental 
work, we chose the ethanol-induced model 
of the gastric ulcer, which is the most 
common animal model for the study of new 
anti-ulcer drugs (Jabri et al., 2017; 
Karampour et al., 2019). Alcohol 
consumption is known as one of the risk 
factors for gastric ulceration (Sumbul et al., 
2011; Lv et al., 2019). The 
pathophysiological background of this 
model is related to the ethanol-induced 
necrotic changed of the gastric mucosa with 
subsequent infiltration of the inflammatory 
cells, and reduction of secretion of 
bicarbonates, gastric mucus, and nitric 
oxide. In addition, ethanol reduces gastric 
blood flow and causes oxidative stress, 
increasing the production of 
malondialdehyde and reducing the 
production of glutathione (Alvarez-Suarez 
et al., 2011; Arab et al., 2015, Al-Quraishy 
et al., 2017). It was shown that the 
antioxidant activity of the alcohol extract of 
barberry leaves is due to the presence of 
polyphenols in it (Berłowski et al., 2013), 
though its gastroprotective effect in peptic 
ulcer was not assessed before (Majeed et 
al., 2015). An in vitro study demonstrated 
the antioxidative cytoprotective effect of 
Berberis aristata on the gastric epithelial 
cells co-cultured with H. pylori (Zaidi et al., 
Gastroprotective effect of Berberis vulgaris 
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2012). A few investigations demonstrated 
the gastroprotective effect of extracts of 
different parts of Berberis plants in peptic 
ulcer and other diseases of the 
gastrointestinal tract, but most of them used 
fruits and seeds, while leaves mainly 
remain unattended (Farzaei et al., 2013; 
Majeed et al., 2015; Rahimi-Madiseh et al., 
2017; Alamzeb et al., 2018 Kalmarzi et al., 
2019) 
Our results confirmed data of other 
authors (Majeed et al., 2015; Kalmarzi et 
al., 2019) regarding the gastroprotective 
effect of B. vulgaris through its astringent 
and local anti-inflammatory action and 
complemented it with new information 
regarding stimulation of PGE2 secretion by 
gastric mucosa which proved to be an 
additional powerful protective factor which 
was not described before in research on 
defensive mechanisms of this plant against 
ulcerogenic agents. 
The antioxidant and anti-inflammatory 
effect of BV in our model of a gastric ulcer, 
allowed us to preserve the cells of the 
gastric mucosa from ethanol-induced 
damage and maintain its functional activity 
in relation to the production of protective 
gastric mucus and prostaglandins (Farzaei 
et al., 2015). This protective effect can 
explain the high content of prostaglandin 
E2 in the mucosa determined in our 
experiments.  
Obviously, this effect is not associated 
with an action of BV on the acidity of the 
gastric secretions, since atropine, which 
reduces the secretion of hydrochloric acid, 
did not significantly affect the content of 
prostaglandins in the gastric mucosa. Our 
results correlate with the previous findings 
(Berenguer et al., 2006) regarding 
prostaglandin-associated gastroprotective 
effect in modelled peptic ulcer of another 
plant (Rhizophora mangle L.) known for 
high content of tannins. Our results do not 
support the statement (Kupeli et al., 2002; 
Yesilada and Kupeli, 2002; Rad et al., 
2017) regarding the provocation of 
gastrointestinal ulceration by the Berberis 
crataegina root extract. This contradiction 
may be explained by the application of root 
rather than leave extract in these studies and 
their use of another Berberis species 
(Berberis crataegina DC). In these papers, 
the ulceration effect of Berberis crataegina 
DC root extract is referred to the presence 
of alkaloids, mainly berberine in it, while in 
our study the content of alkaloids in BV was 
low, and we associate its gastroprotective 
effect with tannins and flavonoids present 
in it at much higher concentrations.  
The results of the present study strongly 
indicate the gastroprotective effects of BV 
in experimental ethanol-induced gastric 
ulcer. The ameliorating effect of ethanolic 
extract of the B. vulgaris leaves on the 
gastric ulcer might be assigned to the 
observed prostaglandin-associated anti-
oxidative and anti-inflammatory properties 
of the polyphenolic complex of flavonoids 
and tannins present in BV. It is well known 
that flavonoids show anti-ulcer and anti-
inflammatory activities, and most of the 
flavonoids are potent antioxidants. Tannins 
exhibit a proven anti-inflammatory, 
antimicrobial, and astringent action. Both 
tannins and flavonoids are known to 
increase secretion of prostaglandins in the 
gastric mucosa which exhibit accelerated 
reparative processes and its strengthened 
defensive potential. However, further 
studies are required to examine the anti-
ulcer efficacy of BV in a clinical setup.  
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